Population pharmacogenomics: impact on public health and drug development

被引:5
|
作者
Patrinos, George P. [1 ,2 ,3 ]
机构
[1] Univ Patras, Dept Pharm, Sch Hlth Sci, Patras, Greece
[2] United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates
[3] United Arab Emirates Univ, Zayed Bin Sultan Ctr Hlth Sci, Al Ain, U Arab Emirates
基金
欧盟地平线“2020”;
关键词
clinical trials; drug development; genetic testing; personalized therapy; pharmacogenomics; population genomics; public health genomics; ECONOMIC-EVALUATION; GENOMIC MEDICINE; CLINICAL-TRIALS; CHALLENGES; COUNTRIES; VARIANTS; WORLD;
D O I
10.2217/pgs-2017-0166
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:3 / 6
页数:4
相关论文
共 50 条
  • [1] The Impact of Pharmacogenomics Research on Drug Development
    Liou, Shyh-Yuh
    Stringer, Fran
    Hirayama, Masashi
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (01) : 2 - 8
  • [2] Population Pharmacogenomics for Precision Public Health in Colombia
    Deepali Nagar, Shashwat
    Melissa Moreno, A.
    Norris, Emily T.
    Rishishwar, Lavanya
    Conley, Andrew B.
    O'Neal, Kelly L.
    Velez-Gomez, Sara
    Montes-Rodriguez, Camila
    Jaraba-Alvarez, Wendy, V
    Torres, Isaura
    Medina-Rivas, Miguel A.
    Valderrama-Aguirre, Augusto
    King Jordan, I
    Esteban Gallo, Juan
    [J]. FRONTIERS IN GENETICS, 2019, 10
  • [3] Pharmacogenomics and Public Health
    Veenstra, D.
    Burke, W.
    [J]. PUBLIC HEALTH GENOMICS, 2009, 12 (03) : 131 - 133
  • [4] Public Health Pharmacogenomics
    Patrinos, George P.
    [J]. PUBLIC HEALTH GENOMICS, 2014, 17 (5-6) : 245 - 247
  • [5] Pharmacogenomics and its potential impact on drug and formulation development
    Regnström, K
    Burgess, DJ
    [J]. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2005, 22 (05): : 465 - 492
  • [6] Pharmacogenetics, pharmacogenomics and population admixture: implications for drug development and prescription
    Guilherme Suarez-Kurtz
    [J]. Nature Reviews Genetics, 2005, 6 (10) : 721 - 721
  • [8] Pharmacogenomics in drug development
    Salerno, RA
    [J]. GENETIC ENGINEERING NEWS, 2005, 25 (12): : 14 - 14
  • [9] Population-level pharmacogenomics for precision drug development in dementia
    Cacabelos, Ramon
    [J]. EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2018, 3 (03): : 163 - 188
  • [10] Pharmacogenetics, pharmacogenomics and population admixture: implications for drug development and prescription
    Guilherme Suarez-Kurtz
    [J]. Nature Reviews Genetics, 2005, 6 (10) : 721 - 721